- Ligustilide
-
- $150.00 / 1kg
-
2025-04-30
- CAS:4431-01-0
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 500kg
- Ligustilide
-
- $0.00 / 1kg
-
2025-04-28
- CAS:4431-01-0
- Min. Order: 1kg
- Purity: 0.99
- Supply Ability: 1000kg
- Ligustilide
-
- $10.00 / 1KG
-
2025-04-23
- CAS:4431-01-0
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 10 mt
|
| | Ligustilide Basic information |
| Product Name: | Ligustilide | | Synonyms: | 1(3H)-Isobenzofuranone,3-butylidene-4,5-dihydro-;(3Z)-3-Butylidene-4,5-dihydroisobenzofuran-1(3H)-one;3-[(Z)-Butylidene]-1,3,4,5-tetrahydroisobenzofuran-1-one;3-[(Z)-Butylidene]-4,5-dihydrophthalide;3-Butylidene-4,5-dihydroisobenzofuran-1(3H)-one;Angelica Extract Powder;3-BUTYLIDEN-4,5-DIHYDRO-3H-ISOBENZOFURAN-1-ONE;3-BUTYLIDENE-4,5-DIHYDROPHTHALIDE | | CAS: | 4431-01-0 | | MF: | C12H14O2 | | MW: | 190.24 | | EINECS: | | | Product Categories: | chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract | | Mol File: | 4431-01-0.mol |  |
| | Ligustilide Chemical Properties |
| Boiling point | 377.9±11.0 °C(Predicted) | | density | 1.10±0.1 g/cm3(Predicted) | | storage temp. | -20°C, protect from light, stored under nitrogen | | solubility | DMSO : 100 mg/mL (525.65 mM; Need ultrasonic) | | form | Oil | | color | Colorless to light yellow | | Stability: | Light Sensitive | | LogP | 1.710 (est) |
| Risk Statements | 22/23 | | Safety Statements | 24/25 | | RIDADR | 2810 | | HS Code | 29322090 |
| | Ligustilide Usage And Synthesis |
| Uses | Ligustilide, is a dihydrophthalide, and an active ingredients of umbelliferous plants as Angelica sinensis and Ligusticum chuanxiong, having wide range of pharmacology effects on neuroprotection, vasodilatation, anti-caner and anti-tumor, analgesia and anti-inflammation. | | Definition | ChEBI: A natural product found in Ligusticum porteri. | | Biological Activity | Ligustilide can inhibit the proliferation of and cell cycle progression of vascular smooth muscle cells and inhibits vasoconstriction. It increases vasodilation, anti-thrombosis, and serotonergic activity and decreases platelet aggregation. It has been shown to have broad applications in the study and treatment of cardiovascular diseases and ischemic brain injury. Ligustilide has the ability to reduce neurogenic and inflammatory pain. Thus, it can be used as a potential therapeutic agent to tre at several pain syndromes including primary dysmenorrhoea. |
| | Ligustilide Preparation Products And Raw materials |
|